Vertex Pharmaceuticals Incorporated shares owned by Mn Services Vermogensbeheer B.V.
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Mn Services Vermogensbeheer B.V.
from 13F filings
Historical chart of Mn Services Vermogensbeheer B.V. investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by Mn Services Vermogensbeheer B.V. consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Vertex Pharmaceuticals Incorporated by Mn Services Vermogensbeheer B.V.
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $49M | 122k | 406.89 |
| 2023-09-30 | $44M | 126k | 347.74 |
| 2023-06-30 | $43M | 123k | 351.91 |
| 2023-03-31 | $40M | 126k | 315.07 |
| 2022-12-31 | $36M | 123k | 288.78 |
| 2022-09-30 | $41M | 142k | 289.54 |
| 2022-06-30 | $42M | 150k | 281.79 |
| 2022-03-31 | $49M | 187k | 260.97 |
| 2021-12-31 | $44M | 198k | 219.60 |
| 2021-09-30 | $35M | 194k | 181.39 |
| 2021-06-30 | $32M | 191k | 170.02 |
| 2020-12-31 | $54M | 229k | 236.34 |
| 2020-09-30 | $61M | 225k | 272.12 |
| 2020-06-30 | $64M | 221k | 290.31 |
| 2020-03-31 | $52M | 219k | 237.95 |
| 2019-12-31 | $51M | 233k | 218.95 |
| 2019-09-30 | $38M | 227k | 169.42 |
| 2019-06-30 | $24M | 131k | 183.38 |
| 2019-03-31 | $8.1M | 44k | 183.95 |
| 2018-12-31 | $6.3M | 43k | 144.96 |
| 2018-09-30 | $7.9M | 41k | 192.74 |
| 2018-06-30 | $6.8M | 40k | 169.96 |
| 2018-03-31 | $6.5M | 40k | 162.99 |
| 2017-12-31 | $4.9M | 39k | 124.80 |
| 2017-09-30 | $6.2M | 41k | 152.04 |
| 2017-06-30 | $5.3M | 41k | 128.87 |
| 2017-03-31 | $676k | 6.6k | 102.19 |
| 2016-12-31 | $443k | 6.3k | 69.92 |
| 2016-09-30 | $553k | 6.3k | 87.28 |
| 2016-06-30 | $482k | 6.2k | 77.43 |
| 2016-03-31 | $428k | 6.1k | 69.70 |
More positions owned by Mn Services Vermogensbeheer B.V.
View all positions for Mn Services Vermogensbeheer B.V.
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated